MitraClip for the treatment of heart failure with mitral regurgitation: A cost-effectiveness analysis in a Chinese setting
BackgroundHeart failure (HF) with mitral regurgitation is associated with decreased survival. Guideline-directed medical therapy and transcatheter edge-to-edge repair (TEER) are the main options for HF patients with severe mitral regurgitation who are considered high-risk or prohibitive. To date, th...
Main Authors: | Wengang Xia, Kangning Han, Yake Lou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.970118/full |
Similar Items
-
Percutaneous Mitral Valve Repair with the MitraClip System in the Current Clinical Practice
by: Sergio Sorrentino, et al.
Published: (2021-01-01) -
Hemodynamics in mitral regurgitation – before and after correction with MitraClip
by: Ivo Petrov, et al.
Published: (2021-12-01) -
Edge-to-Edge Transcatheter Mitral Valve Repair Using PASCAL vs. MitraClip: A Systematic Review and Meta-Analysis
by: Kaveh Hosseini, et al.
Published: (2023-05-01) -
Re‐do MitraClip in patients with functional mitral valve regurgitation and advanced heart failure
by: Michael M. Kreusser, et al.
Published: (2021-12-01) -
Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients With Primary Mitral Regurgitation Who Are Candidates for Surgery: Design and Rationale of the REPAIR MR Trial
by: Patrick M. McCarthy, et al.
Published: (2023-02-01)